One day in November 2001, Mukesh Ambani, Chairman of Reliance Group, the largest private sector enterprise in India, mandated K.V. Subramaniam to build a life sciences business from scratch. With no formal education in biology, he was initially at sea. But, endowed with a corporate business development background, and a do-or-die spirit, he set out to systematically understand and create a research-driven, biotechnology-leveraged company with a differentiated ...
